Michiel S. Van Der Heijden, Joseph M. Jacob, Félix Guerrero-Ramos, Christopher M. Pieczonka, Philipp Spiegelhalder, Katie S. Murray, Katharine Stromberg, Jason Martin, Abhijit Shukla, Christopher J. Cutie, Kristi Bertzos, Shalaka Hampras, Hussein Sweiti, Manish Patel, Thierry Roumeguere, Charles Van Praet, Harm Arentsen, Bart De Troyer, Frederic Baekelandt, Karel Decaestecker, Girish Kulkarni, Wassim Kassouf, George Vrabec, Sabrina Falkowski, Geraldine Pignot, Evanguelos Xylinas, Morgan Roupret, Marc Colombel, Romain Mathieu, Benoit Wolff, Marc-Olivier Timsit, Xavier Artignan, Stephane Droupy, Herve Lang, Mathieu Roumiguié, Frank Bladou, Catherine Becht, Martin Bögemann, Phillipp Spiegelhalder, Jorg Klier, Tilman Toderhofer, Eva Hellmis, Petros Sountoulides, Konstantinos Hatzimouratidis, Giuseppe Simone, Luca Galli, Frederico Deho, Andrea Minervini, Andrea Necchi, Takashi Kawahara, Shuya Kandori, Masao Tsujihata, Shinji Urakami, Taek Won Kang, Ja Hyeon Ku, Kang Su Cho, Wonho Jung, Ho Kyung Seo, Jong Kil Nam, Diederik Somford, Michiel Van der Heijden, Antonio Morais, Vania Grenha, Jorge Rebola, Sandra Custodio, Vagif Atduev, Denis Kholtdobin, Jose Luis Alvarez-Ossorio Fernandez, Javier Romero Otero, Felix Guerrero Ramos, Bernardo Herrera Imbroda, Pol Servian Vives, Nelson Canales Casco, Mario Eduardo Alvarez Maestro, David Morris, Siamak Daneshmand, Curtis Dunshee, Daniel Zainfeld, Katie Murray, Laurence Belkoff, Peter Earl Clark, Yair Lotan, Joseph Jacob, David Cahn, Christopher Pieczonka, Amy Luckenbaugh, Marc Pliskin, Jason Hafron, Eugene Cone, Brian Mazzarella, Richard David. "TAR-200 for Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study." Journal of Clinical Oncology, 2025. doi:10.1200/jco-25-01651